Neuland Laboratories Limited (BOM:524558)

Neuland Laboratories Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	185,257	154,946	80,588	23,087	13,171	26,788
Market Cap Growth	60.45%	92.27%	249.07%	75.28%	-50.83%	636.62%
Enterprise Value	184,432	154,137	80,232	24,941	15,076	28,580
Last Close Price	14439.45	12066.95	6265.25	1788.67	1016.15	2063.59
PE Ratio	105.19	59.57	26.86	14.12	20.64	33.22
Forward PE	49.34	44.12	25.58	20.20	15.19	28.71
PS Ratio	13.93	10.49	5.17	1.94	1.38	2.86
PB Ratio	12.15	10.16	6.28	2.32	1.57	3.41
P/TBV Ratio	14.93	12.49	8.05	3.24	2.36	5.32
P/FCF Ratio	-	139.69	68.58	13.49	-	31.90
P/OCF Ratio	-	48.82	30.86	9.73	21.81	14.15
PEG Ratio	1.10	0.59	0.59	0.59	0.59	0.59
EV/Sales Ratio	13.87	10.44	5.15	2.09	1.58	3.05
EV/EBITDA Ratio	77.68	47.53	17.49	8.93	10.74	19.72
EV/EBIT Ratio	107.08	58.16	19.89	10.82	15.69	26.07
EV/FCF Ratio	-	138.96	68.28	14.58	-	34.04
Debt / Equity Ratio	0.10	0.10	0.07	0.13	0.29	0.23
Debt / EBITDA Ratio	0.66	0.48	0.21	0.46	1.67	1.23
Debt / FCF Ratio	-	1.42	0.81	0.75	-	2.17
Asset Turnover	-	0.74	0.91	0.80	0.70	0.73
Inventory Turnover	-	2.04	2.33	2.26	2.16	2.38
Quick Ratio	-	1.21	1.10	0.95	0.69	0.63
Current Ratio	-	2.45	2.15	1.73	1.60	1.49
Return on Equity (ROE)	-	18.53%	26.36%	17.83%	7.85%	10.78%
Return on Assets (ROA)	-	8.26%	14.77%	9.73%	4.44%	5.36%
Return on Capital (ROIC)	7.04%	10.83%	20.16%	13.08%	5.86%	7.05%
Return on Capital Employed (ROCE)	-	15.50%	28.70%	20.20%	9.40%	11.50%
Earnings Yield	0.95%	1.68%	3.72%	7.08%	4.85%	3.01%
FCF Yield	-	0.72%	1.46%	7.41%	-2.83%	3.13%
Dividend Yield	0.08%	0.10%	0.22%	0.56%	0.49%	0.24%
Payout Ratio	-	6.91%	4.28%	3.92%	6.03%	3.18%
Buyback Yield / Dilution	-0.01%	-	-	-	-	-
Total Shareholder Return	0.08%	0.10%	0.22%	0.56%	0.49%	0.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.